Filter
902
Filtered Results: 902
Text search:
General
Pharmaceutical
Council
Featured
Recommendations
66
New Publications
257
Language
Document type
No document type
507
Studies & Reports
172
Guidelines
117
Strategic & Response Plan
45
Manuals
28
Training Material
13
Fact sheets
10
Situation Updates
7
Resource Platforms
2
Brochures
1
Countries / Regions
India
56
Kenya
42
South Africa
35
Ethiopia
28
Nigeria
27
Global
24
Uganda
24
Sierra Leone
21
Western and Central Europe
21
Tanzania
20
Zambia
20
Nepal
17
Ghana
17
Zimbabwe
15
Bangladesh
14
Rwanda
13
Namibia
13
Ukraine
12
Malawi
12
Lesotho
10
Philippines
10
Africa
9
Liberia
9
Eastern Europe
8
Eswatini/ Swaziland
8
Syria
7
Cambodia
7
Myanmar / Burma
6
Latin America and the Carribbean
5
Botswana
5
Indonesia
5
South–East Asia Region
4
Eastern Europe and Central Asia
4
Pakistan
4
Guinea
3
Congo, Democratic Republic of
3
United Kingdom
3
East and Southern Africa
3
Thailand
2
Chile
2
Cameroon
2
Albania
2
Fiji
2
Burkina Faso
2
Peru
2
Mozambique
2
USA
2
Haiti
2
Asia
2
Jordan
2
Germany
2
West and Central Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Jamaica
2
Lebanon
2
Brazil
2
Moldova
2
Egypt
2
Sudan
2
South Sudan
2
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Benin
1
China
1
Iran
1
Laos
1
Niger
1
Bulgaria
1
Venezuela
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Maldives
1
Southern Africa
1
Russia
1
Yemen
1
Romania
1
Palestine
1
Central African Republic
1
Mali
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
441
Clinical Guidelines
45
Public Health
38
Key Resources
36
Women & Child Health
11
Pharmacy & Technologies
9
Capacity Building
5
Toolboxes
AMR
89
Pharmacy
75
COVID-19
63
Mental Health
56
HIV
43
TB
31
Global Health Education
22
Caregiver
20
NCDs
19
Conflict
19
Rapid Response
15
Health Financing Toolbox
15
Planetary Health
14
NTDs
13
Specific Hazards
12
Ebola & Marburg
8
Refugee
6
Polio
5
Natural Hazards
3
Disability
3
Social Ethics
2
Cholera
1
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Antimicrobial resistance (AMR) is a global public health crisis that resulted in 1.14 million deaths in 2021. According to the Institute for Health Metrics and Evaluation estimates, 96 416 of these deaths occurred in the World Health Organization (WHO) Eastern Mediterranean Region. All 22 countr...
The Country Cooperation Strategy is the World Health Organization (WHO)’s reference for country work guiding planning and resource allocation through alignment with national health priorities and harmonization with other development partners. It clarifies roles and functions of WHO in supporting t...
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
This paper was developed to support AMR coordination committees and others tasked with addressing AMR at country level to do just that. Drawing on the published literature and the operational experience and expertise of different LMICs, the paper points to six key strategies for success and offers a...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and...
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities and utilities
should always be properly designed, bu...
Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
Promoting People's Health to Enhance Social-economic Development
A Focus on the Journey to Self-Reliance for Preventing Child and Maternal Deaths . June 2018
The 2018 Acting on the Call report focuses on 25 countries’ journeys to self-reliance for preventing child and maternal deaths. Self-reliance is a country’s ability to finance and implement solution...
The 2018 Acting on the Call report focuses on 25 countries’ journeys to self-reliance for preventing child and maternal deaths. Self-reliance is a country’s ability to finance and implement solution...
